Electromed (NYSE:ELMD) vs. Competitive Technologies (OTCMKTS:CTTC) Financial Comparison

Electromed (NYSE:ELMD) and Competitive Technologies (OTCMKTS:CTTC) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk.

Valuation & Earnings

This table compares Electromed and Competitive Technologies”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Electromed	$71.75 million	4.77	$5.15 million	$1.17	35.30
Competitive Technologies	N/A	N/A	N/A	N/A	N/A

Electromed has higher revenue and earnings than Competitive Technologies.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Electromed and Competitive Technologies, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Electromed	0	1	3	0	2.75
Competitive Technologies	0	0	0	0	0.00

Electromed presently has a consensus target price of $37.50, suggesting a potential downside of 9.20%. Given Competitive Technologies’ higher possible upside, analysts plainly believe Competitive Technologies is more favorable than Electromed.

Profitability

This table compares Electromed and Competitive Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Electromed	11.34%	15.71%	13.37%
Competitive Technologies	N/A	N/A	N/A

Insider & Institutional Ownership

40.8% of Electromed shares are owned by institutional investors. 10.5% of Electromed shares are owned by insiders. Comparatively, 17.5% of Competitive Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Electromed beats Competitive Technologies on 7 of the 9 factors compared between the two stocks.

About Electromed

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

About Competitive Technologies

Calmare Therapeutics Incorporated, a medical device company, develops and commercializes products and technologies for chronic neuropathic pain and wound care affliction patients in the United States. Its flagship medical device is Calmare Pain Therapy Device, a non-invasive and non-addictive modality for the treatment of chronic and neuropathic pain. The company was formerly known as Competitive Technologies, Inc. and changed its name to Calmare Therapeutics Incorporated in August 2014. Calmare Therapeutics Incorporated was founded in 1968 and is based in Fairfield, Connecticut.